Nevertheless, several limitations remain in the current body of research
Clinical trials demonstrate A1C reductions of 1.5-2.0 percentage points in patients using semaglutide
Using a method known as "target trial emulation," they compared patients initiating GLP-1 drugs with those initiating sodium-glucose cotransporter-2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors
N ng vai tr quan trng trong vic bo v c th chng li cc gc t do, vi khun v virus gy bnh, gim nguy c mc bnh ho, st, cm ma v nhim trng
Figure 4 Effects on Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS), which is mainly manifested as sparse ovulation or non-ovulation, high levels of androgens, ovarian polycystic changes, obesity, and infertility, is the most common endocrine and metabolic disorder in women of childbearing age (139)